• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

面部皮肤护理指数的制定:一项针对皮肤癌患者的健康相关结局指数。

Development of the facial skin care index: a health-related outcomes index for skin cancer patients.

作者信息

Matthews B Alex, Rhee John S, Neuburg Marcy, Burzynski Mary L, Nattinger Ann B

机构信息

Health Policy Institute, Center for Patient Care & Outcomes Research, Department of Otolaryngology and Communication Sciences, Froedtert Memorial Lutheran Hospital and Medical College of Wisconsin, Milwaukee, Wisconsin 53226-0509, USA.

出版信息

Dermatol Surg. 2006 Jul;32(7):924-34; discussion 934. doi: 10.1111/j.1524-4725.2006.32197.x.

DOI:10.1111/j.1524-4725.2006.32197.x
PMID:16875475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1810190/
Abstract

BACKGROUND

Existing health-related quality-of-life (HRQOL) tools do not appear to capture patients' specific skin cancer concerns.

OBJECTIVE

To describe the conceptual foundation, item generation, reduction process, and reliability testing for the Facial Skin Cancer Index (FSCI), a HRQOL outcomes tool for skin cancer researchers and clinicians.

METHODS

Participants in Phases I to III consisted of adult patients (N=134) diagnosed with biopsy-proven nonmelanoma cervicofacial skin cancer. Data were collected via self-report surveys and clinical records.

RESULTS

Seventy-one distinct items were generated in Phase I and rated for their importance by an independent sample during Phase II; 36 items representing six theoretical HRQOL domains were retained. Test-retest I results indicated that four subscales showed adequate reliability coefficients (alpha=0.60 to 0.91). Twenty-six items remained for test-retest II. Results indicated excellent internal consistency for emotional, social, appearance, and modified financial/work subscales (range 0.79 to 0.95); test-retest correlation coefficients were consistent across time (range 0.81 to 0.97; lifestyle omitted).

CONCLUSION

Pretesting afforded the opportunity to select items that optimally met our a priori conceptual and psychometric criteria for high data quality. Phase IV testing (validity and sensitivity before surgery and 4 months after Mohs micrographic surgery) for the 20-item FSCI is under way.

摘要

背景

现有的健康相关生活质量(HRQOL)工具似乎无法涵盖患者对皮肤癌的具体担忧。

目的

描述面部皮肤癌指数(FSCI)的概念基础、条目生成、缩减过程和信度测试,这是一种供皮肤癌研究人员和临床医生使用的HRQOL结果工具。

方法

第一阶段至第三阶段的参与者为经活检证实患有非黑色素瘤面颈部皮肤癌的成年患者(N = 134)。数据通过自我报告调查和临床记录收集。

结果

第一阶段生成了71个不同的条目,并在第二阶段由一个独立样本对其重要性进行评分;保留了代表六个理论HRQOL领域的36个条目。重测I结果表明,四个子量表显示出足够的信度系数(α = 0.60至0.91)。26个条目留作重测II。结果表明,情感、社会、外观和修改后的财务/工作子量表具有出色的内部一致性(范围为0.79至0.95);重测相关系数在不同时间是一致的(范围为0.81至0.97;生活方式部分省略)。

结论

预测试提供了选择条目的机会,这些条目最佳地满足了我们对高数据质量的先验概念和心理测量标准。20条目FSCI的第四阶段测试(手术前和莫氏显微外科手术后4个月的效度和敏感性)正在进行中。

相似文献

1
Development of the facial skin care index: a health-related outcomes index for skin cancer patients.面部皮肤护理指数的制定:一项针对皮肤癌患者的健康相关结局指数。
Dermatol Surg. 2006 Jul;32(7):924-34; discussion 934. doi: 10.1111/j.1524-4725.2006.32197.x.
2
Creation of a quality of life instrument for nonmelanoma skin cancer patients.为非黑色素瘤皮肤癌患者创建一种生活质量评估工具。
Laryngoscope. 2005 Jul;115(7):1178-85. doi: 10.1097/01.MLG.0000166177.98414.5E.
3
A Spanish version of the Skin Cancer Index: a questionnaire for measuring quality of life in patients with cervicofacial nonmelanoma skin cancer.《皮肤癌指数西班牙语版》:一种用于评估头颈部非黑素瘤皮肤癌患者生活质量的问卷。
Br J Dermatol. 2015 Jan;172(1):160-8. doi: 10.1111/bjd.13173. Epub 2014 Dec 25.
4
FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery.用于评估面部皮肤癌手术后患者报告结局的 FACE-Q 皮肤癌模块。
Br J Dermatol. 2018 Jul;179(1):88-94. doi: 10.1111/bjd.16671. Epub 2018 May 23.
5
Nonmelanoma skin cancer: disease-specific quality-of-life concerns and distress.非黑色素瘤皮肤癌:特定疾病的生活质量问题与困扰
Oncol Nurs Forum. 2014 Jan 1;41(1):57-65. doi: 10.1188/14.ONF.57-65.
6
Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.皮肤基底细胞癌和鳞状细胞癌治疗的生活质量结果
J Invest Dermatol. 2007 Jun;127(6):1351-7. doi: 10.1038/sj.jid.5700740. Epub 2007 Feb 15.
7
Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer.非黑色素瘤皮肤癌患者生活质量评估工具的验证
Arch Facial Plast Surg. 2006 Sep-Oct;8(5):314-8. doi: 10.1001/archfaci.8.5.314.
8
Patient experiences and outcomes following facial skin cancer surgery: A qualitative study.面部皮肤癌手术后的患者体验与结局:一项定性研究。
Australas J Dermatol. 2016 Aug;57(3):e100-4. doi: 10.1111/ajd.12323. Epub 2015 Apr 2.
9
Delayed treatment and continued growth of nonmelanoma skin cancer.非黑素瘤皮肤癌的延迟治疗和持续生长。
J Am Acad Dermatol. 2011 May;64(5):839-48. doi: 10.1016/j.jaad.2010.06.028. Epub 2010 Nov 5.
10
Patient-reported outcome measures in nonmelanoma skin cancer of the face: a systematic review.患者报告的面部非黑素瘤皮肤癌结局测量指标:系统评价。
Br J Dermatol. 2013 Jun;168(6):1187-94. doi: 10.1111/bjd.12269.

引用本文的文献

1
Patient-Reported Outcome Measures for Mohs Reconstruction: A Systematic Review.Mohs 重建术的患者报告结局指标:一项系统评价
OTO Open. 2024 Dec 18;8(4):e70054. doi: 10.1002/oto2.70054. eCollection 2024 Oct-Dec.
2
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI).维莫德吉停药后的长期疗效以及使用皮肤病生活质量指数(DLQI)评估患者的健康相关生活质量。
Dermatol Ther (Heidelb). 2019 Dec;9(4):719-724. doi: 10.1007/s13555-019-00323-4. Epub 2019 Sep 10.
3
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test.维莫德吉在转移性和晚期基底细胞癌患者中的实际疗效:不良事件特征及使用皮肤病生活质量指数(DLQI)测试评估健康相关生活质量
Dermatol Ther (Heidelb). 2019 Sep;9(3):505-510. doi: 10.1007/s13555-019-0303-4. Epub 2019 Jun 4.
4
Validation of the English and French versions of the Brief Health Care Climate Questionnaire.《简短医疗保健氛围问卷》英文和法文版本的验证
Health Psychol Open. 2017 Oct 2;4(2):2055102917730675. doi: 10.1177/2055102917730675. eCollection 2017 Jul-Dec.
5
UK-based prospective cohort study to anglicise and validate the FACE-Q Skin Cancer Module in patients with facial skin cancer undergoing surgical reconstruction: the PROMISCR (Patient-Reported Outcome Measure in Skin Cancer Reconstruction) study.在接受面部皮肤癌手术重建的患者中使 FACE-Q 皮肤癌模块英文化并验证其的英国前瞻性队列研究:PROMISCR(皮肤癌重建中的患者报告结局测量)研究。
BMJ Open. 2017 Sep 24;7(9):e016182. doi: 10.1136/bmjopen-2017-016182.
6
Responsiveness of the Spanish Version of the "Skin Cancer Index".《皮肤癌指数》西班牙语版本的反应性
J Skin Cancer. 2016;2016:8180348. doi: 10.1155/2016/8180348. Epub 2016 Oct 9.
7
Engaging Patients as Partners in Developing Patient-Reported Outcome Measures in Cancer-A Review of the Literature.让患者作为合作伙伴参与制定癌症患者报告结局测量指标——文献综述
Support Care Cancer. 2016 Aug;24(8):3543-9. doi: 10.1007/s00520-016-3151-0. Epub 2016 Mar 28.
8
Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report.托姆刀放疗联合西妥昔单抗治疗,随后以西妥昔单抗作为不可切除皮肤鳞状细胞癌的单药治疗:一例病例报告
BMC Dermatol. 2014 Sep 30;14:15. doi: 10.1186/1471-5945-14-15.
9
Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care.黑色素瘤随访期间坚持皮肤自我检查医嘱的障碍与促进因素
BMC Dermatol. 2013 Mar 1;13:3. doi: 10.1186/1471-5945-13-3.
10
Skin reactions and quality of life after x-ray therapy of Basal cell carcinoma.基底细胞癌X线治疗后的皮肤反应与生活质量
J Skin Cancer. 2012;2012:825095. doi: 10.1155/2012/825095. Epub 2012 Dec 20.

本文引用的文献

1
The meaning of quality of life in patients being treated for advanced breast cancer: a qualitative study.晚期乳腺癌患者生活质量的意义:一项定性研究。
Psychooncology. 2004 Oct;13(10):729-39. doi: 10.1002/pon.788.
2
Skin cancer and quality of life: assessment with the Dermatology Life Quality Index.皮肤癌与生活质量:使用皮肤病生活质量指数进行评估
Dermatol Surg. 2004 Apr;30(4 Pt 1):525-9. doi: 10.1111/j.1524-4725.2004.30169.x.
3
Quality of life and sun-protective behavior in patients with skin cancer.皮肤癌患者的生活质量与防晒行为
Arch Otolaryngol Head Neck Surg. 2004 Feb;130(2):141-6. doi: 10.1001/archotol.130.2.141.
4
Quality of life assessment in nonmelanoma cervicofacial skin cancer.非黑色素瘤头颈部皮肤癌的生活质量评估
Laryngoscope. 2003 Feb;113(2):215-20. doi: 10.1097/00005537-200302000-00004.
5
Psychosocial adjustment in head and neck cancer: the impact of disfigurement, gender and social support.头颈癌患者的心理社会调适:毁容、性别及社会支持的影响
Head Neck. 2003 Feb;25(2):103-12. doi: 10.1002/hed.10174.
6
A randomized trial of skin cancer prevention in aquatics settings: the Pool Cool program.水上环境中皮肤癌预防的随机试验:Pool Cool项目。
Health Psychol. 2002 Nov;21(6):579-87.
7
Health status and life satisfaction among breast cancer survivor peer support volunteers.乳腺癌幸存者同伴支持志愿者的健康状况与生活满意度
Psychooncology. 2002 May-Jun;11(3):199-211. doi: 10.1002/pon.550.
8
Lifestyle high-risk behaviors and demographics may predict the level of participation in sun-protection behaviors and skin cancer primary prevention in the United States: results of the 1998 National Health Interview Survey.生活方式高风险行为和人口统计学特征可能预测美国防晒行为和皮肤癌一级预防的参与程度:1998年美国国家健康访谈调查结果
Cancer. 2001 Sep 1;92(5):1315-24. doi: 10.1002/1097-0142(20010901)92:5<1315::aid-cncr1453>3.0.co;2-i.
9
Psychosocial characteristics of individuals with non-stage IV melanoma.非IV期黑色素瘤患者的心理社会特征。
J Clin Oncol. 2001 Jun 1;19(11):2844-50. doi: 10.1200/JCO.2001.19.11.2844.
10
Changes in patient perception and behavior following Mohs micrographic surgery.莫氏显微外科手术后患者认知及行为的变化
J Cutan Med Surg. 2001 Jan-Feb;5(1):14-7. doi: 10.1177/120347540100500104.